Organization · Venture Studio
Autobahn Labs, Inc.
Autobahn Labs, Inc. is a Palo Alto-based virtual drug discovery incubator that partners with academic institutions to co-found biotech companies. It focuses on transforming early-stage research into preclinical drug candidates by providing funding and expertise.
Overview
What Autobahn Labs, Inc. does
What Autobahn Labs, Inc. is
Autobahn Labs, Inc. is a Palo Alto-based virtual drug discovery incubator that partners with academic institutions to co-found biotech companies. It focuses on transforming early-stage research into preclinical drug candidates by providing funding and expertise.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Studio
- Founded
- Founded in 2020
- Approximate age
- About 6 years
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
What Venture studio means
A venture studio is an organization that systematically creates new startups by generating or sourcing ideas, validating them, building early products, recruiting founders or operators, providing shared resources, and retaining meaningful equity in the companies it helps create.
Open the glossary entryOfficial channels
Find Autobahn Labs, Inc. elsewhere
Open the official website or a supported primary organization account.
Capability profile
Autobahn Labs, Inc. as a funder
Investment thesis
Autobahn Labs aims to bridge the translational gap in academic drug discovery by co-founding biotech companies with academic researchers, leveraging a model that combines intellectual, physical, and financial capital to advance early-stage drug candidates.
Focus narrative
Autobahn Labs invests in early-stage scientific research, particularly in the biopharmaceutical sector, to develop preclinical drug candidates. By partnering with academic institutions, Autobahn Labs identifies novel concepts that may lack sufficient resources for development. The organization provides up to $5 million per project, operational support, and access to a robust drug discovery platform to advance projects from target validation to preclinical development.
Value beyond capital
Autobahn Labs adds value to its portfolio companies by providing not only funding but also operational expertise and access to a global network of scientists and drug discovery infrastructure through its partnership with Evotec SE. This comprehensive support helps academic spinouts navigate the complexities of drug development and enhances their chances of success in bringing new therapies to market.
Terms and economics
- Typical check
- $0–$5,000,000
- Sweet spot
- $5,000,000
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- North America
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
While specific portfolio companies are not disclosed, Autobahn Labs has established partnerships with several prestigious academic institutions, including UCLA, UCSF, UCSD, Cold Spring Harbor Laboratory, Boston Children's Hospital, University of Pennsylvania, and USC. These collaborations focus on accelerating drug discovery and translating academic research into new medicines.
Common questions
What to know about Autobahn Labs, Inc.
Upseed classifies Autobahn Labs, Inc. under the Venture Studio organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.